A carregar...

XI-006 induces potent p53-independent apoptosis in Ewing sarcoma

There is an imperious need for the development of novel therapeutics for the treatment of Ewing sarcoma, the second most prevalent solid bone tumour observed in children and young adolescents. Recently, a 4-nitrobenzofuroxan derivative, XI-006 (NSC207895) was shown to diminish MDM4 promoter activity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Pishas, Kathleen I., Adwal, Alaknanda, Neuhaus, Susan J., Clayer, Mark T., Farshid, Gelareh, Staudacher, Alexander H., Callen, David F.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4476092/
https://ncbi.nlm.nih.gov/pubmed/26095524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep11465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!